Liège, Belgium, April 18, 2022 -07:30 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (“Mithra” or the “Company”), a company dedicated to women’s health, today announces the extension of the capital commitment agreement with LDA Capital Limited ( “LDA Capital”) for a period of two additional years, as well as the increase in the amount of the commitment by EUR 25 million.
Disclaimer
Mithra Pharmaceuticals SA published this content on April 18, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on April 18, 2022 05:43:07 UTC.